NCT07408648 2026-02-13
A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor Therapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Not yet recruiting
Clinical Trials
7 trialsNCT06818916 2025-12-03
Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma
Beijing Children's Hospital
Phase NA Recruiting
NCT07101627 2025-08-03
A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer Therapy
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Not yet recruiting
NCT05442632 2024-03-13
Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy
Fudan University
Phase 2 Recruiting
NCT06099925 2023-10-25
The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Malignancies
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Unknown
NCT05261646 2023-09-28
A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Withdrawn
NCT06036966 2023-09-14
The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Unknown